FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS

This invention relates to new fused heterocyclic derivatives having affinity to S1P receptors, a pharmaceutical composition containing said compounds, as well as the use of said compounds for the preparation of a medicament for treating, alleviating or preventing diseases and conditions in which any...

Full description

Saved in:
Bibliographic Details
Main Authors SMID PIETER, SLIEDREGT LEONARDUS A.J.M, VAN DONGEN MARIA J.P, DEN HARTOG JACOBUS A.J, COOLEN HEIN K.A.C, IWEMA BAKKER WOUTER I
Format Patent
LanguageEnglish
Korean
Published 15.01.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to new fused heterocyclic derivatives having affinity to S1P receptors, a pharmaceutical composition containing said compounds, as well as the use of said compounds for the preparation of a medicament for treating, alleviating or preventing diseases and conditions in which any S1P receptor is involved or in which modulation of the endogenous S1P signaling system via any S1P receptor is involved.
Bibliography:Application Number: KR20137003333